Barriers and facilitators of adherence to the use of ASICA, a digital app designed to support people previously treated for melanoma: concise report of a qualitative study

Author:

Ntessalen Maria1,McCorkindale Sajan1,Krasniqi Albana1ORCID,Morgan Heather M1,Allan Julia L1,Murchie Peter1ORCID

Affiliation:

1. Institute of Applied Health Sciences, Academic Primary Care , Polwarth Building, Aberdeen Scotland , UK

Abstract

Abstract We developed the Achieving Self-directed Integrated Cancer Aftercare (ASICA) in melanoma app to support monthly total-skin self-examinations (TSSE) by people previously treated for melanoma. A randomized 12-month trial demonstrated ASICA supported optimal monthly TSSE adherence in a third of participants (ClinicalTrials.gov NCT03328247). However, a further third of participants adhered well initially but subsequently dropped off, and a final third did not adhere at all. This follow-up qualitative study investigated trial participants’ perceptions of barriers and facilitators to TSSE adherence using the app. Three former trial participants participated in a single focus group and 11 participated in new semistructured telephone interviews. These were analysed thematically alongside secondary analysis of 13 qualitative interviews conducted during the trial. All transcripts were recorded, transcribed and analysed thematically. Five themes encompassing barriers and facilitators to ASICA adherence emerged. These were: technology, role of others, tailoring, disease journey and competing priorities. These data will inform further development of ASICA to increase user adherence.

Funder

Cancer Research UK

Publisher

Oxford University Press (OUP)

Subject

Dermatology

Reference10 articles.

1. Guidelines of care for the management of primary cutaneous melanoma;Swetter;J Am Acad Dermatol,2019

2. Screening, early detection, and trends for melanoma: current status (2000–2006) and future directions;Geller;J Am Acad Dermatol,2007

3. Total skin self-examination at home for people treated for cutaneous melanoma: development and pilot of a digital intervention;Murchie;BMJ Open,2015

4. The Achieving Self-Directed Integrated Cancer Aftercare intervention for detection of recurrent and second primary melanoma in survivors of melanoma: pilot randomized controlled trial;Murchie;JMIR Cancer,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3